• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羧肽酶A与一种失活剂形成的两种晶体形式的晶体结构。

Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms.

作者信息

Chai J J, He C, Li M, Tang L, Luo M

机构信息

Institute of Biophysics, Chinese Academy of Sciences, Beijing.

出版信息

Protein Eng. 1998 Oct;11(10):841-5. doi: 10.1093/protein/11.10.841.

DOI:10.1093/protein/11.10.841
PMID:9862201
Abstract

Two different crystal forms of carboxypeptidase A (CPA) complexed with an inactivator were obtained by the method of hanging drop vapor diffusion. The inactivator, 2-benzyl-3-iodo-propanoic acid (BIPA), binds covalently to an active site residue Glu270 of CPA. The complexes were crystallized in the space group P2(1) (CPA-I) and P2(1)2(1)2(1) (CPA-II), respectively. The structures of both crystal forms were determined by molecular replacement using the native CPA crystal structure as the search model. The final crystallographic residuals are 0.163 for CPA-I and 0.152 for CPA-II. Except for the modification of Glu270, the inactivator exhibits normal binding mode compared with other ligand complexes of CPA. In the final electron density difference maps (2Fo-Fc, Fo-Fc), the density of the iodo ion could not be found in both crystal forms while the conserved water molecule remains coordinated to Zn2+ as in the native CPA. Comparisons of the complexes of CPA-BIPA with the native CPA and the CPA-D-Phe complex are presented. The mechanism of the inactivation of CPA and its implication for catalytic mechanism were discussed.

摘要

通过悬滴气相扩散法获得了两种与失活剂复合的羧肽酶A(CPA)不同晶体形式。失活剂2-苄基-3-碘丙酸(BIPA)与CPA的活性位点残基Glu270共价结合。复合物分别在空间群P2(1)(CPA-I)和P2(1)2(1)2(1)(CPA-II)中结晶。两种晶体形式的结构均通过分子置换法确定,使用天然CPA晶体结构作为搜索模型。CPA-I的最终晶体学残余因子为0.163,CPA-II为0.152。除了Glu270的修饰外,与CPA的其他配体复合物相比,失活剂表现出正常的结合模式。在最终的电子密度差图(2Fo-Fc,Fo-Fc)中,两种晶体形式均未发现碘离子的密度,而保守水分子仍像在天然CPA中一样与Zn2+配位。给出了CPA-BIPA复合物与天然CPA和CPA-D-苯丙氨酸复合物的比较。讨论了CPA失活的机制及其对催化机制的影响。

相似文献

1
Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms.羧肽酶A与一种失活剂形成的两种晶体形式的晶体结构。
Protein Eng. 1998 Oct;11(10):841-5. doi: 10.1093/protein/11.10.841.
2
Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography.通过X射线晶体学测定的三种羧肽酶A-膦酸酯复合物结构的比较。
Biochemistry. 1991 Aug 20;30(33):8171-80. doi: 10.1021/bi00247a012.
3
Native carboxypeptidase A in a new crystal environment reveals a different conformation of the important tyrosine 248.处于新晶体环境中的天然羧肽酶A显示出重要的酪氨酸248的不同构象。
Biochemistry. 1998 Nov 24;37(47):16555-64. doi: 10.1021/bi981678i.
4
Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.N-(羟基氨基羰基)苯丙氨酸对羧肽酶A抑制作用的立体化学研究:该抑制剂对映体对与羧肽酶A的结合模式
Bioorg Med Chem. 2002 Jun;10(6):2015-22. doi: 10.1016/s0968-0896(01)00429-1.
5
Three high-resolution crystal structures of cadmium-substituted carboxypeptidase A provide insight into the enzymatic function.镉取代的羧肽酶A的三种高分辨率晶体结构为酶的功能提供了深入见解。
J Biol Inorg Chem. 2002 Apr;7(4-5):490-9. doi: 10.1007/s00775-001-0324-0. Epub 2002 Feb 15.
6
Carboxypeptidase A: native, zinc-removed and mercury-replaced forms.羧肽酶A:天然形式、去锌形式和汞取代形式。
Acta Crystallogr D Biol Crystallogr. 1998 May 1;54(Pt 3):289-305. doi: 10.1107/s0907444997010445.
7
Refined structure of bovine carboxypeptidase A at 1.25 A resolution.
Acta Crystallogr D Biol Crystallogr. 2003 Feb;59(Pt 2):323-33. doi: 10.1107/s0907444902015706. Epub 2003 Jan 23.
8
Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.基于X射线晶体结构和催化反应途径设计基于机制的羧肽酶A失活剂。
Bioorg Med Chem. 1998 Sep;6(9):1613-22. doi: 10.1016/s0968-0896(98)00082-0.
9
Crystal structure of the complex between carboxypeptidase A and the biproduct analog inhibitor L-benzylsuccinate at 2.0 A resolution.羧肽酶A与双产物类似物抑制剂L-苄基琥珀酸复合物在2.0埃分辨率下的晶体结构。
J Mol Biol. 1992 Jan 20;223(2):573-8. doi: 10.1016/0022-2836(92)90671-6.
10
Inhibition of carboxypeptidase A by excess zinc: analysis of the structural determinants by X-ray crystallography.过量锌对羧肽酶A的抑制作用:通过X射线晶体学分析结构决定因素。
FEBS Lett. 1997 Jan 6;400(3):336-40. doi: 10.1016/s0014-5793(96)01412-3.

引用本文的文献

1
Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase.嘌呤核苷与人类脱氧胞苷激酶不同结合模式的阐明。
J Med Chem. 2008 Jul 24;51(14):4219-25. doi: 10.1021/jm800134t. Epub 2008 Jun 21.